Caspase-cleaved amyloid precursor protein in Alzheimer's disease

Brain Pathology

Volumn 12, Issue 4, 2002, Pages 430-441

  Ayala Grosso, Carlos ^a   Ng, Gordon ^b   Roy, Sophie ^b   Robertson, George S ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CASPASE;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; METABOLIC ENCEPHALOPATHY; NERVE CELL NECROSIS; NERVE DEGENERATION; PROTEIN DEGRADATION; PYRAMIDAL NERVE CELL; SENILE PLAQUE;

EID: 0036793843     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2002.tb00460.x     Document Type: Article

References (46)

1. Bancher C, Lassmann H, Breitschopf H, Jellinger KA (1997) Mechanisms of cell death in Alzheimer's disease. J Neural Transm Suppl 50:141-152.
2. Braak H, Braak E (1991) Neuropathological stagging of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259.
3. Campbell SK, Switzer RC, Martin TL (1987) Alzheimer's plaques and tangles: A controlled and enhanced silver-staining method. Soc Neurosci Abs 13:678.
4. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS (1998) Alzheimer's disease. Etiologies, pathophysiology, cognitive reserve and treatment opportunities. Neurology 51 (Suppl 1):S2-S17.
5. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurology 27:457-464.
6. Delacourte A, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 2:1158-1165.
7. Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19:1-8.
8. Gervais F, Xu D, Robertson GS, Vaillancourt J, Zhu Y, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M et al (1999) Involvement of caspase in proteolytic cleavage of Alzheimer's disease amyloid-b precursor protein and amyloidogenic Aβ peptide formation. Cell 97:395-406.
9. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41:17-24.
10. Grant SM, Ducatenzeiler A, Szyf M, Cuello AC. (2000) Aβ immunoreactive material is present in several intracellular compartments in transfected neuronally differentiated, P19 cell expressing the human amyloid-precursor protein. Journal of Alzh Dis 2:207-222.
11. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med 4:957-962.
12. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 17:4212-4222.
13. Ivins KJ, Thornton PL, Rohn TT, Cotman CW (1999) Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol Dis 6:440-449.
14. Kitamura Y, Shimoshama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T (1998) Alteration of proteins regulating apoptosis: bcl-2, bcl-x, bax, bak,bad, ICH-1, and CPP32 in Alzheimer's disease. Brain Research 780:260-269.
15. Kitamura Y, Taniguchi T, Shimohama S (1999) Apoptotic cell death in neurons and glial cells: implications for Alzheimer's disease. Jpn J Pharmacol 79:1-5.
16. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 89:35-41.
17. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, Salvesen GS, Koo EH, Bredesen DE (2000) A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 6:397-404.
18. Lucassen PJ, Chung WC, Kamphorst W, Swaab DF (1997) DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 56:887-900.
19. Marks N, Berg MJ (1999) Recent advances on neuronal caspases in development and neurodegeneration. Neurochem Int 35:195-220.
20. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA (1998) Caspase dependent fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathl Exp Neurol 57:1041-1052.
21. Mattson MP, Duan W, Pedersen WA, Culmsee C (2001) Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6:69-81.
22. Neve RL, McPhie DL, Chen Y (2000) Alzheimer's disease: a dysfunction of the amyloid precursor protein. Brain Res 886:54-66.
23. Nijhawan D, Honarpour N, Wang X (2000) Apoptosis in neural development and disease. Annu Rev Neurosci 23:73-87.
24. Nishimura T, Akiyama H, Yonehara S, Kondo H, Ikeda K, Kato M, Iseki E, Kosaka K (1995) Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 95:137-145.
25. Pellegrini L, Passer BJ, Tabaton M, Ganjei JK, D'Adamio L (1999) Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8. J Biol Chem 274:21011-21016.
26. Perry G, Nunomura A, Smith MA (1998) A suicide note from Alzheimer disease neurons? Nat Med 4(8):957-962.
27. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB (2000) Neuroprotection by the inhibition of apoptosis. Brain Pathol 2:283-292.
28. Rohn TT, Head E, Su JH, Anderson AJ, Bahr BA, Cotman CW, Cribbs DH (2001) Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol 158:189-198.
29. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, Johnson EM Jr, Roth KA (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathl Exp Neurol 58:1020-1026.
30. Selznick LA, Zheng TS, Flavell RA, Rakic P, Roth KA (2000) Amyloid beta-induced neuronal death is bax-dependent but caspase-independent. J Neuropathl Exp Neurol 59:271-279.
31. Shimohama S, Tanino H, Fujimoto S (1999) Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem Bioph Res Comm 256:381-384.
32. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
33. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155:1459-1466.
34. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathl Exp Neurol 57:456-464.
35. Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW (2001) Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res 898:350-357.
36. Su JH, Deng G, Cotman CW (1997) Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res 774:193-199.
37. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533.
38. Terry RD (2000)Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 59:1118-1119.
39. Terry RD (2001) An honorable compromise regarding amyloid in Alzheimer disease. Ann Neurol 49:684.
40. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE (1996) In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlation with senile plaques and disease progression. J Neuropathol Exp Neurol 55:1134-1142.
41. Tsang SY, Tam SC, Bremner I, Burkitt MJ (1996) Copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical. Biochem J 317:13-16.
42. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacana E, Sunderland T, Zhao B, Kusiak JW, Wasco W, D'Adamio L (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274:1710-1713.
43. Yamatsuji T, Matsui T, Okamoto T, Komatsuzaki K, Takeda S, Fukumoto H, Iwatsubo T, Suzuki N, Asami-Odaka A, Ireland S, Kinane TB, Giambarella U, Nishimoto I (1996) G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272:1349-1352.
44. Yang F, Sun X, Beech W, Teter B, Wu S, Sigel J, Vinters HV, Frautschy SA, Cole GM (1998) Antibody to caspasecleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol 152:379-389.
45. Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802-809.
46. Zheng TS, Hunot S, Kuida K, Momoi T, Srinivasan A, Nicholson DW, Lazebnik Y, Flavell RA (2000) Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med 11:1241-1247.